Search Results - "Esselmann, H."

Refine Results
  1. 1
  2. 2

    Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer’s disease and other neurodegenerative dementias by Genius, J., Klafki, H., Benninghoff, J., Esselmann, H., Wiltfang, J.

    “…In light of the dramatically increasing prevalence of Alzheimer’s disease (AD) to be expected in the future, the development of novel therapeutics, improved…”
    Get full text
    Journal Article
  3. 3

    Validation of amyloid-β peptides in CSF diagnosis of neurodegenerative dementias by BIBL, M, MOLLENHAUER, B, WILTFANG, J, LEWCZUK, P, ESSELMANN, H, WOLF, S, TRENKWALDER, C, OTTO, M, STIENS, G, RÜTHER, E, KORNHUBER, J

    Published in Molecular psychiatry (01-07-2007)
    “…Biomarkers for differential diagnosis of the three most frequent degenerative forms of dementia, Alzheimer's disease (AD), dementia with Lewy bodies (DLB) and…”
    Get full text
    Journal Article
  4. 4

    From Bones to Brain: 50 Years of Star Trek and Changes in the Stigmatization of Psychological Disorders by Basilowski, M., Schönfeld, B., Esser, S., Jatho, A., Kownatka, M., Signerski-Krieger, J., Esselmann, H., Grabemann, M., Mette, C., Strunz, L., Zimmermann, M., Lajcsak, E., Scherbaum, N., Wiltfang, J., Kis, B., Abdel-Hamid, M.

    Published in Current psychology (New Brunswick, N.J.) (01-10-2020)
    “…The Star Trek franchise currently includes five spin-off series and 13 motion pictures. Star Trek’s central theme is the utopian future of mankind, but the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Guideline-adherent inpatient psychiatric psychotherapeutic treatment of behavioral and psychological symptoms of dementia : Normative definition of personnel requirements by Radenbach, K, Retzlik, J, Meyer-Rötz, S H, Wolff-Menzler, C, Wolff, J, Esselmann, H, Godemann, F, Riemenschneider, M, Wiltfang, J, Jessen, F

    Published in Nervenarzt (01-09-2017)
    “…Dementia is of increasing medical and societal relevance. Hospitalization of dementia patients is mostly due to behavioral and psychological symptoms of…”
    Get full text
    Journal Article
  7. 7

    Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment by Mamo, J C L, Jian, L, James, A P, Flicker, L, Esselmann, H, Wiltfang, J

    Published in Annals of clinical biochemistry (01-07-2008)
    “…Plasma amyloid beta-peptide (Abeta) can compromise the blood-brain barrier, contributing to cerebrovascular alterations and amyloid angiopathy in Alzheimer's…”
    Get more information
    Journal Article
  8. 8

    Decreased β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease by OTTO, M, ESSELMANN, H, KORNHUBER, J, KRETZSCHMAR, H. A, POSER, S, WILTFANG, J, SCHULZ-SCHAEFFER, W, NEUMANN, M, SCHRÖTER, A, RATZKA, P, CEPEK, L, ZERR, I, STEINACKER, P, WINDL, O

    Published in Neurology (14-03-2000)
    “…Decreased levels of Abeta1-42 are found in CSF of patients with AD. Because early stages of Creutzfeldt-Jakob disease (CJD) and AD share several clinical…”
    Get full text
    Journal Article
  9. 9

    Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations by Bibl, M., Mollenhauer, B., Wolf, S., Esselmann, H., Lewczuk, P., Kornhuber, J., Wiltfang, J.

    Published in Journal of Neural Transmission (01-05-2007)
    “…Cerebrospinal fluid (CSF) carboxyterminally truncated amyloid-beta (A beta ) peptides, A beta 1-42 and tau protein were evaluated in 30 patients with…”
    Get full text
    Journal Article
  10. 10

    Tauopathies and synucleinopathies: do cerebrospinal fluid beta-amyloid peptides reflect disease-specific pathogenesis? by Mollenhauer, B, Bibl, M, Esselmann, H, Steinacker, P, Trenkwalder, C, Wiltfang, J, Otto, M

    Published in Journal of Neural Transmission (01-07-2007)
    “…To evaluate variations in amyloid beta (Abeta) peptide pattern in cerebrospinal fluid (CSF) in neurodegenerative disorders. A recently established quantitative…”
    Get full text
    Journal Article
  11. 11

    CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies by Bibl, M, Mollenhauer, B, Esselmann, H, Lewczuk, P, Trenkwalder, C, Brechlin, P, Rüther, E, Kornhuber, J, Otto, M, Wiltfang, J

    Published in Journal of Neural Transmission (01-11-2006)
    “…Differential diagnosis of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) is often crucial. CSF Tau protein and Amyloid-beta (A beta) peptides…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Immune complexes of auto-antibodies against Aβ1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients by HENKEL, A. W, DITTRICH, P. S, WILTFANG, J, GROEMER, T. W, LEMKE, E. A, KLINGAUF, J, KLAFKI, H. W, LEWCZUK, P, ESSELMANN, H, SCHWILLE, P, KORNHUBER, J

    Published in Molecular psychiatry (01-06-2007)
    “…The diagnostic potential of large Aβ-peptide binding particles (LAPs) in the cerebrospinal fluid (CSF) of Alzheimer's dementia (AD) patients and non-AD…”
    Get full text
    Journal Article
  15. 15

    Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients by Henkel, A W, Dittrich, P S, Groemer, T W, Lemke, E A, Klingauf, J, Klafki, H W, Lewczuk, P, Esselmann, H, Schwille, P, Kornhuber, J, Wiltfang, J

    Published in Molecular psychiatry (01-06-2007)
    “…The diagnostic potential of large A beta-peptide binding particles (LAPs) in the cerebrospinal fluid (CSF) of Alzheimer's dementia (AD) patients and non-AD…”
    Get full text
    Journal Article
  16. 16

    P01-496 - Comparative study of the effects of intranasal insulin on memory deficits in type 2 diabetes and early Alzheimer's dementia concept and study scope by Siemann, H, Müller, B, Stein, E.M, Esselmann, H, Loos, S, Ennen, J, Lehnert, H, Hallschmid, M, Wiltfang, J

    Published in European psychiatry (2011)
    “…Introduction Recent data support the view that the neurodegeneration underlying sporadic Alzheimer's Disease (AD) is in part related to brain insulin…”
    Get full text
    Journal Article
  17. 17

    Tyr687 dependent APP endocytosis and Abeta production by Rebelo, Sandra, Vieira, Sandra Isabel, Esselmann, Hermann, Wiltfang, Jens, da Cruz e Silva, Edgar F, da Cruz e Silva, Odete A B

    Published in Journal of molecular neuroscience (01-02-2007)
    “…The neurotoxic Abeta peptide is derived by proteolytic processing from the Alzheimer's amyloid precursor protein (APP), whose short cytoplasmic domain contains…”
    Get full text
    Journal Article
  18. 18

    3-D Coculture of Hepatic Sinusoidal Cells with Primary Hepatocytes—Design of an Organotypical Model by Bader, A., Knop, E., Kern, A., Böker, K., Frühauf, N., Crome, O., Esselmann, H., Pape, C., Kempka, G., Sewing, K.-Fr

    Published in Experimental cell research (10-07-1996)
    “…Models for cocultures of parenchymal (PC) and nonparenchymal cells (NPC) of the liver relied on mixing the cells in a two-dimensional configuration or on…”
    Get full text
    Journal Article
  19. 19
  20. 20